Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

Ethan Allen CEO Farooq Kathwari Talks Tariffs, Cautious Consumers
06:32

Yale Budget Lab Executive Director Martha Gimbel Talks Tariffs
05:24

Apollo's Jim Zelter Talks Iran War, Private Credit Concerns
10:35